Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia

被引：7
|
作者：
Le, Quy [1 ]
Tang, Thao [1 ]
Leonti, Amanda [1 ]
Castro, Sommer [1 ]
McKay, Cyd Nourigat [1 ]
Perkins, LaKeisha [1 ]
Pardo, Laura [2 ]
Kirkey, Danielle [1 ]
Hylkema, Tiffany [1 ]
Call, Lindsey [1 ]
Manselle, Makia [1 ]
Abrahams, Cristina [3 ]
Bedard, Kristin [3 ]
Molina, Arturo [3 ]
Brodersen, Lisa Eidenshinck [2 ]
Loken, Michael R. [2 ]
Tarlock, Katherine [1 ,5 ]
Meshinchi, Soheil [1 ,4 ,5 ]
Loeb, Keith R. [1 ,6 ,7 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA
[2] Hematologics Inc, Seattle, WA USA
[3] Sutro Biopharma, South San Francisco, CA USA
[4] Univ Washington, Dept Pediat, Seattle, WA USA
[5] Childrens Oncol Grp, Monrovia, CA USA
[6] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[7] Fred Hutch Canc Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 09期
关键词：
INVARIANT CHAIN; PROLIFERATION; SURVIVAL;
D O I：
10.1182/bloodadvances.2022008303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1666 / 1670
页数：5
相关论文
共 50 条
  • [31] Characterization of SGN-CD123A, APotent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia
    Li, Fu
    Sutherland, May Kung
    Yu, Changpu
    Walter, Roland B.
    Westendorf, Lori
    Valliere-Douglass, John
    Pan, Lucy
    Cronkite, Ashley
    Sussman, Django
    Klussman, Kerry
    Ulrich, Michelle
    Anderson, Martha E.
    Stone, Ivan J.
    Zeng, Weiping
    Jonas, Mechthild
    Lewis, Timothy S.
    Goswami, Maitrayee
    Wang, Sa A.
    Senter, Peter D.
    Law, Che-Leung
    Feldman, Eric J.
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 554 - 564
  • [32] Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies
    Li, Lingna
    Tong, Wenyong
    Lau, Megan
    Fells, Katherine
    Zhu, Tong
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Yan, Zheng
    Deng, Dalun
    Takeshita, Ken
    Kaufmann, Gunnar F.
    Ji, Henry
    Li, Hui
    Zhang, Hong
    BLOOD, 2019, 134
  • [33] An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer
    Jacob, Joan
    Francisco, Liezl E.
    Chatterjee, Treena
    Liang, Zhengdong
    Subramanian, Shraddha
    Liu, Qingyun J.
    Rowe, Julie H.
    Carmon, Kendra S.
    BRITISH JOURNAL OF CANCER, 2023, 128 (08) : 1592 - 1602
  • [34] Evaluation of the DLL3-targeting Antibody-Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma
    Krytska, Kateryna
    Casey, Colleen E.
    Pogoriler, Jennifer
    Martinez, Daniel
    Rathi, Komal S.
    Farrel, Alvin
    Berko, Esther R.
    Tsang, Matthew
    Sano, Renata R.
    Kendsersky, Nathan
    Erickson, Stephen W.
    Teicher, Beverly A.
    Isse, Kumiko
    Saunders, Laura
    Smith, Malcolm A.
    Maris, John M.
    Mosse, Yael P.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (07): : 616 - 623
  • [35] Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET
    van Scheltinga, Anton G. T. Terwisscha
    Ogasawara, Annie
    Pacheco, Glenn
    Vanderbilt, Alexander N.
    Tinianow, Jeff N.
    Gupta, Nidhi
    Li, Dongwei
    Firestein, Ron
    Marik, Jan
    Scales, Suzie J.
    Williams, Simon-Peter
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (01) : 134 - 142
  • [36] Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma
    Tu, Jianghua
    Toh, Yukimatsu
    Aldana, Adela M.
    Wen, Jake J.
    Wu, Ling
    Jacob, Joan
    Li, Li
    Pan, Sheng
    Carmon, Kendra S.
    Liu, Qingyun J.
    PHARMACEUTICS, 2024, 16 (07)
  • [37] THERAPY OF ADVANCED BLADDER CANCER BY TARGETING HYAL2 WITH ANTIBODY-DRUG CONJUGATE: PRECLINICAL STUDY
    O'Malley, Padraic
    Donelan, William
    Hsieh, Meng-Lun
    Li, Shiwu
    Nguyen, Brianna
    Crispen, Paul
    Kusmartsev, Sergei
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1084 - E1084
  • [38] An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia
    Zheng, Bing
    Yu, Shang-Fan
    del Rosario, Geoffrey
    Leong, Steven R.
    Lee, Genee Y.
    Vij, Rajesh
    Chiu, Cecilia
    Liang, Wei-Ching
    Wu, Yan
    Chalouni, Cecile
    Sadowsky, Jack
    Clark, Vanessa
    Hendricks, Angela
    Poon, Kirsten Achilles
    Chu, Wayne
    Pillow, Thomas
    Schutten, Melissa M.
    Flygare, John
    Polson, Andrew G.
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1358 - 1368
  • [39] Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)
    Cole, Frances M.
    Laszlo, George S.
    Lunn-Halbert, Margaret C.
    Kehret, Allie R.
    Zweidler-McKay, Patrick A.
    Rodriguez-Arboli, Eduardo
    Wu, David
    Nyberg, Kyle E.
    Li, Junyang
    Lim, Sheryl Y. T.
    Lakshmikanthan, Sribalaji
    Walter, Roland B.
    BLOOD, 2024, 144 : 2751 - 2751
  • [40] Antibody-drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance
    Murali, M.
    Kumar, A. R.
    Nair, B.
    Pavithran, K.
    Devan, A. R.
    Pradeep, G. K.
    Nath, L. R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (03): : 407 - 431
12345